Our results suggested that linc00265 upregulation increased the expression of USP22 at mRNA and protein levels, and linc00265 downregulation attenuated the USP22 expression levels in osteosarcoma cells (Figures 5E, F). The gene discussed is USP22; the disease is osteosarcoma.